Work

Opening Remarks: Dyslipidemia in Women

Year: 2025
Type: article
Abstract: I feel honored to contribute to this special issue on lipid disorders in women in the form of a preface to IJCDW.ere indeed is a great need to research the available data from various sources and come out with guidelines to be followed for the benefit of Indian women with dyslipidemia.e format is well laid out, and all the contributing authors have done a great job.Dr. Hemanth Satpathy has given a panoramic view of dyslipidemia in pregnancy and how to rectify it.[1] Dr. Dayasagar Rao et al. [2] have well discussed the need to have targeted guidelines for Indian women.Dr. Lalita et al. [3] have given a nice contribution to understanding the genetic and ethnic determination of dyslipidemia in women and also discussed the paucity of data pertaining to women in various clinical trials.Dr. Harish et al. [4] have discussed the implications of LP(a), remnant cholesterol, and nonhigh-density lipoproteins (HDL) cholesterol in women.is is a lesser-known domain in lipid understanding in all and specifically in women.Dr. Priya et al. [5] have gone into the futuristic novel agents and their safety, efficacy aspects.is will add to our current pharmacotherapeutic strategies.Dr. Rammohan et al. [6] have elucidated on statin therapy in Indian women with dyslipidemia and the role of nonpharmacological strategies.Dr. Ramya et al. [7] have discussed the role of inclisiran and Small interfering -Ribonucleic acid (siRNA)-based lipid-lowering agents.is new frontier will be a very exciting prospect in the near future.Dr. Ritu Bhatia has delved into new HDL-targeted therapies.As we know, we have very few current options to deal with HDL.[8] Dr. Saeko et al. [9] have given us gender-specific guidelines insight for our clinical practice.Dr. Anuradha et al. [10] have us peep into the diagnosis of subclinical atherosclerosis in women which is of great significance in the prevention of atherosclerotic cardiovascular disease in women.Dr. Asha Mahilmaran et al. [11] have discussed dyslipidemia across the biological and physiological life span of women and gender differences along with hormonal impact.www.ijcdw.
Author: Krishnam Raju Penmetcha
Institution: CARE Hospitals
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7115017038
FWCI:
Cites: 11
Cited by:
Related to: